1010 related articles for article (PubMed ID: 22909024)
1. Al amyloidosis.
Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
[TBL] [Abstract][Full Text] [Related]
2. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
3. [AL amyloidosis].
Jaccard A; Desport E; Mohty D; Bridoux F
Rev Med Interne; 2015 Feb; 36(2):89-97. PubMed ID: 25194219
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of AL amyloidosis].
Jaccard A; Bridoux F
Nephrol Ther; 2019 Apr; 15 Suppl 1():S115-S121. PubMed ID: 30981389
[TBL] [Abstract][Full Text] [Related]
6. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
7. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
Elife; 2020 Mar; 9():. PubMed ID: 32151314
[TBL] [Abstract][Full Text] [Related]
8. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
[TBL] [Abstract][Full Text] [Related]
9. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
10. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
[TBL] [Abstract][Full Text] [Related]
11. Renal Amyloidosis: A Clinicopathological Study From a Tertiary Care Hospital in Pakistan.
Ahmed S; Nasir H; Moatasim A; Khalil F
Cureus; 2022 Jan; 14(1):e21122. PubMed ID: 35165578
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of multinodular goiter and primary hyperparathyroidism leads to a diagnosis of AL amyloidosis.
Patel Chavez C; Morales Hernandez MDM; Kresak J; Woodmansee WW
Thyroid Res; 2022 Apr; 15(1):7. PubMed ID: 35440089
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal manifestations of amyloidosis.
Ebert EC; Nagar M
Am J Gastroenterol; 2008 Mar; 103(3):776-87. PubMed ID: 18076735
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
19. AL amyloidosis: advances in diagnostics and treatment.
Ryšavá R
Nephrol Dial Transplant; 2019 Sep; 34(9):1460-1466. PubMed ID: 30299492
[TBL] [Abstract][Full Text] [Related]
20. Primary systemic amyloidosis.
Comenzo RL
Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
